Stocks · Healthcare · Drug Manufacturers - Specialty & Generic
Trulieve Cannabis Corp. TRLV
$10.72 -1.38% Close, Oct 2, 2026 · NYSE · Market cap $1.82B
Next earnings report: Nov 6, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in an uptrend: above its 200-day average for 96 trading days, with the 50-day average above the 200-day.
- Over the past year the stock returned +27.6%, ahead of the S&P 500 by 12.5 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 38%
- Gross marginBottom 45%
- Operating marginBottom 42%
- Accruals (lower is better)Top 6%
- Interest coverBottom 41%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 30%
- Free-cash-flow yieldTop 7%
- EBITDA / enterprise valueBottom 46%
- Sales / enterprise valueTop 24%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 39%
- 6-month returnTop 12%
- 1-year return vs S&P 500Top 38%
- Distance from 52-week highTop 31%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Upside to consensus price targetBottom 40%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 45%
- Maximum drawdown, 3 yearsBottom 38%
- Beta vs S&P 500 (lower is better)Top 27%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Gross margin | 59.5% | — | Bottom 45% | |
| Operating margin | -24.1% | — | Bottom 42% | |
| Net margin | -41.6% | — | — | |
| Free-cash-flow margin | 16.4% | — | — | |
| Return on invested capital | -5.0% | — | Top 38% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -34.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.8%
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -4.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 0.00%
- Share count change, 1 year
- +0.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -0.6%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $15.00
- Target vs current price
- +39.9%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -3616.7% | +6.6% | +7.9% | +38.5% | — |
| May 7, 2026 | +170.8% | -4.9% | -15.1% | +2.0% | -12.2% |
| Feb 26, 2026 | -196.2% | +1.6% | +0.0% | -4.8% | +23.1% |
| Nov 5, 2025 | -65.5% | +2.3% | +4.8% | -9.8% | +7.9% |
| Aug 6, 2025 | -15.9% | -4.9% | +35.1% | +35.1% | +28.1% |
| May 7, 2025 | -131.7% | -2.5% | +0.7% | -10.3% | +5.1% |
| Feb 27, 2025 | -40.6% | +5.6% | +8.2% | -8.2% | +3.1% |
| Nov 5, 2024 | -187.3% | -8.3% | -56.2% | -55.4% | -62.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$2.11 | $0.06 | -3616.7% | $271.0M |
| May 7, 2026 | $0.01 | -$0.01 | +170.8% | $286.8M |
| Feb 26, 2026 | -$0.22 | -$0.07 | -196.2% | $293.1M |
| Nov 5, 2025 | -$0.14 | -$0.08 | -65.5% | $288.2M |
| Aug 6, 2025 | -$0.07 | -$0.06 | -15.9% | $302.1M |
| May 7, 2025 | -$0.17 | -$0.07 | -131.7% | $297.8M |
| Feb 27, 2025 | -$0.31 | -$0.22 | -40.6% | $301.0M |
| Nov 5, 2024 | -$0.32 | -$0.11 | -187.3% | $284.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.82× | — | — | Top 24% |
| Free-cash-flow yield | 10.26% | — | — | Top 7% |
| Earnings yield | -22.85% | — | — | Bottom 30% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 36
- Days above the 200-day average
- 96
- 50-day average slope (20 days)
- +11.8%
- 200-day average slope (20 days)
- +7.1%
- Distance from 50-day average
- +1.2%
- Distance from 200-day average
- +24.2%
- RSI (14)
- 41.9
- Relative volume
- 0.82×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 58.5%
- Volatility vs own 5-year history
- 18th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.70
- Correlation with S&P 500
- 0.11
- Current drawdown from 1-year high
- -17.5%
- Maximum drawdown, 3 years
- -77.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 16, 2021 | Apr 4, 2025 | -93.9% | 1019 days | Not yet recovered |
| Feb 10, 2021 | Mar 8, 2021 | -14.7% | 17 days | 5 days (Mar 15, 2021) |
| Jan 13, 2021 | Jan 27, 2021 | -12.8% | 9 days | 7 days (Feb 5, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.82B
- EPS, diluted (TTM)
- -$2.45
- Revenue (TTM)
- $1.14B
- 52-week range
- $4.62 – $13.28
| FY 2025 | |
|---|---|
| Revenue | $1.18B |
| Gross profit | $711.2M |
| Operating income | $148.3M |
| Net income | -$116.4M |
| EPS (diluted) | -$0.61 |
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|
| Revenue | $302.1M | $288.2M | $293.1M | $286.8M | $271.0M |
| Net income | -$13.8M | -$26.8M | -$42.9M | $2.4M | -$406.1M |
| EPS (diluted) | -$0.07 | -$0.14 | -$0.22 | $0.01 | -$2.10 |
| FY 2025 | |
|---|---|
| Operating cash flow | $272.8M |
| Capital expenditure | -$60.5M |
| Free cash flow | $212.3M |
| Dividends paid | $0 |
| Net share buybacks | $140.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $325.4M
- Total assets
- $2.08B
- Total liabilities
- $1.31B
- Total debt
- $577.3M
- Net debt
- $251.8M
- Shareholders’ equity
- $767.5M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 5,117,058
- Days to cover
- 2.84
- Change vs previous report
- +254.2%
FINRA short interest, settlement date Sep 15, 2026.